Heavy metals exposure regulates secretory lineage in intestinal injury
Project Number1R01ES034400-01A1
Former Number1R56ES034400-01
Contact PI/Project LeaderIN, JULIE GOEUN
Awardee OrganizationUNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
Description
Abstract Text
PROJECT SUMMARY
Over 160,000 abandoned mine waste sites are concentrated in the western United States and continue to
degrade the environment with elevated heavy metals penetrating the surrounding sediment and groundwater.
The sedimentary dust and water used by communities located near abandoned uranium mine (AUM) sites
often exceeds the maximum contamination level for uranium (U, EPA max level 30 μg/L). Chronic exposure to
environmental toxins and heavy metals has been linked to intestinal inflammation, increased susceptibility to
pathogen-induced diseases, and higher incidences of colorectal cancer; all of which have been steadily
increasing in prevalence for the past 40 years. The negative effects of heavy metals on the intestinal
microbiota, barrier permeability, and inhibition of intestinal epithelial healing have been described; however,
transcriptomic changes within the intestinal epithelial cells are largely unknown. Upon ingestion, uranium is
poorly absorbed systemically (~1.5%) and thus distributed through the entire intestine, suggesting even low U
levels are sufficient to cause intestinal damage. Thus, our goals are to characterize particulate dust (referred to
as U-bearing dust, UBD) as an environmental toxicant that damages the intestinal epithelia and determine the
molecular changes that develop as a response to this injury. We have previously characterized the intestinal
mucus layer in human intestinal organoids (HIOs) under homeostasis and pathogen infected conditions, to
characterize HIOs as an intestinal pathophysiological model. Our preliminary data of HIOs exposed to UBD
found that chemical exposure negatively impacts the secretory lineage in the colon, specifically the mucus-
producing goblet cells and hormone-producing enteroendocrine cells. Thus, we hypothesize that UBD has a
direct effect on: 1) the mucosal surface, represented by a thinning mucus layer and goblet cell dysfunction
and 2) the intestinal enteroendocrine cells in the crypt. This leads to increased susceptibility to intestinal
disorders. The following Aims will address these questions in a mechanistic manner. The first aim will
determine the impact of UBD on mucus layer thinning, resulting pro-inflammatory response, and subsequent
goblet cell expansion. The second aim will examine the autophagy pathway in regulating changes in
enteroendocrine hormone secretion and the transcription factor PROX1 as the non-canonical driver of
enteroendocrine cell expansion following UBD chemical injury. There is a need to understand how heavy
metals, especially those naturally occurring as particulates, induce molecular changes in the intestinal epithelia
of exposed individuals to predispose them to intestinal disorders. Successful completion of this proposal will
help us understand the mechanistic underpinnings of environmental-induced injury that may promote colitis or
related diseases, identify potential therapeutic targets, and identify genetic variations that may contribute to
susceptibility.
Public Health Relevance Statement
PROJECT NARRATIVE
Abandoned uranium mines, primarily located on tribal land in the southwest United States, are not remediated
and continue to degrade heavy metals into the surrounding environment, contaminating the sedimentary dust
and ground water with significant concentrations of uranium. Epidemiological data suggests a direct link
between inhalation and ingestion of uranium mine dusts with higher incidences of intestinal inflammation and
diseases. This proposal aims to define and characterize the mechanisms underlying uranium-induced intestinal
dysfunction and long-term consequences in the intestinal epithelia.
National Institute of Environmental Health Sciences
CFDA Code
113
DUNS Number
829868723
UEI
G389MFAYJNG9
Project Start Date
19-September-2024
Project End Date
30-June-2029
Budget Start Date
19-September-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$379,123
Direct Costs
$250,000
Indirect Costs
$129,123
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Environmental Health Sciences
$29,123
2024
National Institute of General Medical Sciences
$350,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01ES034400-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01ES034400-01A1
Patents
No Patents information available for 1R01ES034400-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01ES034400-01A1
Clinical Studies
No Clinical Studies information available for 1R01ES034400-01A1
News and More
Related News Releases
No news release information available for 1R01ES034400-01A1
History
No Historical information available for 1R01ES034400-01A1
Similar Projects
No Similar Projects information available for 1R01ES034400-01A1